Physician profile
Caleb Greer
NPI 1629630702
$3,707.98
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,309 · 2022: $1,483 · 2023: $591 · 2024: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $915.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $722.99 | 2021-2024 | Repatha, Otezla |
| Novo Nordisk INC | $503.19 | 2021-2023 | Ozempic, Rybelsus |
| Biohaven Pharmaceuticals, INC. | $452.34 | 2021 | |
| Abbvie INC. | $374.97 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $344.68 | 2022 | |
| Lilly USA, LLC | $241.87 | 2021-2024 | Jardiance, Emgality |
| Idorsia Pharmaceuticals US INC | $168.07 | 2023-2024 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $163.10 | 2021-2024 | Farxiga |
| Eisai INC. | $142.99 | 2021 | |
| Mayne Pharma Commercial LLC | $131.28 | 2022-2023 | |
| Allergan, INC. | $123.80 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $55.40 | 2021-2022 | |
| Pfizer INC. | $48.76 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $34.93 | 2021 | |
| Relievant Medsystems, INC. | $31.77 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $30.09 | 2022 | |
| Scilex Pharmaceuticals INC. | $29.24 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.78 | 2022 | |
| Arbor Pharmaceuticals, INC. | $19.21 | 2021 | |
| Amarin Pharma, INC. | $16.62 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.41 | 2021 | |
| Depuy Synthes Sales INC. | $12.44 | 2022 | |
| Antares Pharma, INC. | $12.38 | 2022 | |
| Biodelivery Sciences International, INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Greer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.